Patent Application: Reducing Visceral Fat Using Plants and Spices

ChangeBridge: Patent Apps - Therapeutics (A61P)

Published September 26th, 2024

Detected March 27th, 2026

Summary

The USPTO has published a new patent application (US20260083810A1) detailing methods and compositions for reducing visceral fat in mammals using plants and spices such as Dichrostachys glomerata or Cissus quadrangularis. The application was filed on September 26, 2024, and is scheduled for publication on March 26, 2026.

View original document View source feed page

What changed

This document is a patent application filed with the USPTO, not a regulatory rule or guidance. It describes methods and compositions for reducing visceral fat, increasing GLP-1 levels, and other health benefits using specific plant extracts like Dichrostachys glomerata or Cissus quadrangularis. The application details potential health benefits and specific formulations, such as oral dosage units.

As a patent application, it does not impose direct compliance obligations on regulated entities. However, it may be of interest to pharmaceutical and food manufacturers, as well as healthcare providers, involved in the development of weight management or metabolic health products. Companies operating in these sectors should monitor the patent application's progress and consider its implications for their research and development strategies.

Source document (simplified)

← USPTO Patent Applications

METHODS AND COMPOSITIONS FOR REDUCING VISCERAL FAT IN A MAMMAL USING NATURALLY OCCURING PLANTS AND SPICES

Application US20260083810A1 Kind: A1 Mar 26, 2026

Inventors

Shil Kothari, Julius Enyoug Oben

Abstract

Methods and compositions using Dichrostachys glomerata or Cissus quadrangularis separately to provide a variety of health benefits, including but not limited to, increase GLP-1 levels and reduce or decrease visceral fat, food intake, blood lipids, total cholesterol and total glucose in a mammal. In one embodiment, a composition for reducing visceral fat in a mammal is provided where the composition comprises an effective amount of Cissus quadrangularis provided as an oral dosage unit in the form of a pill, capsule, liquid, lozenge or tablet.